Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc. China accounts for 86.3% of net sales.

Employees

5,727

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
15/26/15	4.610 ¥	+0.66%	1,18,32,560
12/26/12	4.580 ¥	+2.23%	2,25,53,570
11/26/11	4.480 ¥	+0.90%	1,20,22,420
10/26/10	4.440 ¥	+1.37%	1,05,73,670
09/26/09	4.380 ¥	0.00%	82,18,125

End-of-day quote Shenzhen S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Shenzhen S.E. Other stock markets 15/06/2026			5-day change	1st Jan Change
4.610 ^CNY	+0.66%		+5.25%	-11.69%

16/06	Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026	CI
27/04	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	657.89Cr 97Cr 84Cr 77Cr 72Cr 135.88Cr 9.19TCr 137.23Cr 911.55Cr 356.07Cr 4.5TCr 364.78Cr 357.05Cr 16TCr	P/E Ratio 2024	18.2x	P/E Ratio 2025	29x
Enterprise Value	508.84Cr 75Cr 65Cr 60Cr 56Cr 105.09Cr 7.11TCr 106.14Cr 705.03Cr 275.4Cr 3.48TCr 282.13Cr 276.16Cr 12TCr	EV / Sales 2024	0.62x	EV / Sales 2025	0.84x
Free-Float	39.04%	Yield 2024	1.9%	Yield 2025	1.05%

16/06	Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026	CI
27/04	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03/04	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
28/25/28	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
09/25/09	Northeast Pharmaceutical Unit Gets Clinical Trial Approval for Glioma Treatment	MT
08/25/08	Northeast Pharmaceutical Appoints CFO	MT
02/25/02	Northeast Pharmaceutical CFO Resigns	MT
26/25/26	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
05/25/05	Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe	MT
28/25/28	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/25/26	Northeast Pharmaceutical Group Co., Ltd. Announces Directorate Appointments	CI
26/25/26	Northeast Pharmaceutical Group Co., Ltd. Approves Cash Dividend on (A Shares) for 2024, Payable on 23 June 2025	CI
17/25/17	Northeast Pharmaceutical's Subsidiary Gets Nod to Market Levocarnitine Oral Solution	MT

1 day	+0.66%
1 week	+5.25%
Current month	-1.07%
1 month	-5.53%
3 months	-13.18%
6 months	-12.52%
Current year	-11.69%

Northeast Pharmaceutical Group Co., Ltd. Share Price

Stocks

000597

CNE0000009G0

Pharmaceuticals

Valuation: Northeast Pharmaceutical Group Co., Ltd.

Chart: Northeast Pharmaceutical Group Co., Ltd.

Latest news : Northeast Pharmaceutical Group Co., Ltd.

Press Releases: Northeast Pharmaceutical Group Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Northeast Pharmaceutical Group Co., Ltd.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	4.3	4.73
1 month	4.3	4.93
Current year	4.3	5.73
1 year	4.3	6.68
3 years	3.72	6.69
5 years	3.72	9.3
10 years	3.72	9.3

Manager	Title	Age	Since
Yong Gang Cai CEO	Chief Executive Officer	46	21/01/2025
Xin Li DFI	Director of Finance/CFO	46	06/09/2025
Dong Sheng Yan IRC	Investor Relations Contact	42	01/07/2024

Director	Title	Age	Since
Kai Zhou CHM	Chairman	62	21/01/2025
Xin Hua Ao BRD	Director/Board Member	62	18/07/2018
Cheng Ren Huang BRD	Director/Board Member	62	18/07/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.
01/22/01	Zhengwei	Buy		36,000	0.0027%
26/22/26	Yan Liu	Buy	Executive/Senior Manager	100	0.0000%
25/22/25	Zhengwei	Buy		28,100	0.0021%

	2024	2025
Net sales	750.26Cr 110.85Cr 96Cr 88Cr 82Cr 154.95Cr 10TCr 156.5Cr 1.04TCr 406.06Cr 5.13TCr 415.99Cr 407.18Cr 18TCr	707.49Cr 104.53Cr 90Cr 83Cr 78Cr 146.12Cr 9.88TCr 147.58Cr 980.27Cr 382.91Cr 4.84TCr 392.28Cr 383.97Cr 17TCr
Net income	41Cr 6.06Cr 5.22Cr 4.8Cr 4.51Cr 8.46Cr 572.3Cr 8.55Cr 57Cr 22Cr 280.26Cr 23Cr 22Cr 969.79Cr	26Cr 3.84Cr 3.31Cr 3.05Cr 2.86Cr 5.37Cr 363.15Cr 5.42Cr 36Cr 14Cr 177.84Cr 14Cr 14Cr 615.38Cr
Net Debt	-287.58Cr -42Cr -37Cr -34Cr -32Cr -59Cr -4.02TCr -60Cr -398.46Cr -155.65Cr -1.97TCr -159.45Cr -156.07Cr -6.8TCr	-149.05Cr -22Cr -19Cr -17Cr -16Cr -31Cr -2.08TCr -31Cr -206.52Cr -81Cr -1.02TCr -83Cr -81Cr -3.53TCr

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.	+0.66%	+5.25%	-13.67%	-11.52%	97Cr
ELI LILLY AND COMPANY	-0.32%	-1.72%	+37.83%	+148.79%	1,00700Cr
JOHNSON & JOHNSON	-2.16%	+1.51%	+50.01%	+43.93%	57TCr
ABBVIE INC.	-2.70%	-0.66%	+15.97%	+63.07%	39TCr
ROCHE HOLDING AG	-0.35%	+1.05%	+20.91%	+18.37%	33TCr
NOVARTIS AG	-0.37%	+1.20%	+24.31%	+32.00%	28TCr
ASTRAZENECA PLC	+0.52%	-2.70%	+22.61%	+12.52%	28TCr
NOVO NORDISK A/S	-0.23%	+5.83%	-42.74%	-48.32%	20TCr
AMGEN INC.	-1.31%	+1.39%	+18.74%	+53.45%	19TCr
GILEAD SCIENCES, INC.	-1.03%	-2.97%	+13.02%	+57.34%	15TCr
Average	-0.46%	+0.82%	+14.70%	+36.96%	33.87TCr
Weighted average by Cap.	-0.40%	-0.03%	+26.48%	+67.10%